Lazard IncLAZ
Price$36.44Intrinsic value$52.3744% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $3.3B+5.0% YoYTTM through 31 Mar 2026
Net Income $277.4M-0.9% YoYTTM through 31 Mar 2026
Free Cash Flow $497.3MTTM through 31 Mar 2026

Margins

Current
Operating Margin10.6%
Net Margin8.4%

Returns

31.5%ROE
6.5%ROA
17.9%ROIC

Balance Sheet Health

Debt / Equity1.92x
Net Debt$668.1M
Cash & Equivalents$1B

Quality Metrics

Piotroski F-Score5 / 9
FCF Margin15.1%
Rule of 4016.1
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $3.2B
Diluted EPS$2.52TTM
'19'20'21'22'23'24'25
FY2025: $2.17

Dividend

$1.00Per share, FY20262.73%Yield-11.9%5-yr growth

Capital Allocation

Capex Intensity0.6%

Segment Performance

SegmentRevenueYoYOutlook
Financial Advisory$1.8B
View details

Ahead of 2030 targets with strong momentum in high-value deals and strategic hires.

Asset Management$1.3B
View details

Expanding product platform with sustainable strategies, quantitative equity, and actively managed ETFs.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.